Opus Genetics, Inc. (IRD) vs Zura Bio Limited (ZURA)

Opus Genetics, Inc. and Zura Bio Limited are both Biotechnology companies. Opus Genetics, Inc. and Zura Bio Limited are of similar size ($405.2M and $398.7M). Zura Bio Limited has the higher net margin (0.00% vs −1,091.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Zura Bio Limited leads on 6 and Opus Genetics, Inc. on 5.

Valuation

Metric IRD ZURA Biotechnology median
P/E n/m n/m 7.88
P/S 46.11 n/m 11.47
P/B n/m 2.60 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 40.67 n/m 10.73
Earnings yield (27.10%) (27.97%) (28.84%)
Free cash flow yield (9.30%) (16.13%) (23.03%)

Profitability

Metric IRD ZURA Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin (513.47%) 0.00% 0.00%
Net margin (1,091.82%) 0.00% 0.00%
Free cash flow margin (412.61%) 0.00% 0.00%
Return on equity (4,796.52%) (71.76%) (57.72%)
Return on assets (163.50%) (62.74%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IRD ZURA Biotechnology median
Revenue growth (TTM) (36.09%) — 5.64%
EPS growth (last fiscal year) 62.79% (76.67%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IRD ZURA Biotechnology median
Debt to equity (2.69) 0.00 0.00
Current ratio 12.19 12.90 4.73
Net debt to EBITDA 1.17 1.45 0.96

Dividend

Metric IRD ZURA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric IRD ZURA Biotechnology median
Market cap 405.16m 398.65m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack